Clark MR - Search Results

1

Preclinical evaluation of UC781 microbicide vaginal drug delivery.

Clark MR, McCormick TJ, Doncel GF, Friend DR. Clark MR, et al. Drug Deliv Transl Res. 2011 Apr;1(2):175-82. doi: 10.1007/s13346-011-0019-1. Drug Deliv Transl Res. 2011. PMID: 25788115

2

Design of a semisolid vaginal microbicide gel by relating composition to properties and performance.

Mahalingam A, Smith E, Fabian J, Damian FR, Peters JJ, Clark MR, Friend DR, Katz DF, Kiser PF. Mahalingam A, et al. Among authors: clark mr. Pharm Res. 2010 Nov;27(11):2478-91. doi: 10.1007/s11095-010-0244-1. Epub 2010 Sep 15. Pharm Res. 2010. PMID: 20842411

3

Preclinical evaluation of anti-HIV microbicide products: New models and biomarkers.

Doncel GF, Clark MR. Doncel GF, et al. Among authors: clark mr. Antiviral Res. 2010 Dec;88 Suppl 1:S10-8. doi: 10.1016/j.antiviral.2010.09.018. Antiviral Res. 2010. PMID: 21109063 Review.

4

Multipurpose prevention technologies: biomedical tools to prevent HIV-1, HSV-2, and unintended pregnancies.

Thurman AR, Clark MR, Doncel GF. Thurman AR, et al. Among authors: clark mr. Infect Dis Obstet Gynecol. 2011;2011:1-10. doi: 10.1155/2011/429403. Epub 2011 Aug 9. Infect Dis Obstet Gynecol. 2011. PMID: 21836811 Free PMC article. Review.

5

A hot-melt extruded intravaginal ring for the sustained delivery of the antiretroviral microbicide UC781.

Clark MR, Johnson TJ, McCabe RT, Clark JT, Tuitupou A, Elgendy H, Friend DR, Kiser PF. Clark MR, et al. Among authors: clark jt. J Pharm Sci. 2012 Feb;101(2):576-87. doi: 10.1002/jps.22781. Epub 2011 Oct 4. J Pharm Sci. 2012. PMID: 21976110

6

Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring.

Moss JA, Malone AM, Smith TJ, Kennedy S, Kopin E, Nguyen C, Gilman J, Butkyavichene I, Vincent KL, Motamedi M, Friend DR, Clark MR, Baum MM. Moss JA, et al. Among authors: clark mr. Antimicrob Agents Chemother. 2012 Feb;56(2):875-82. doi: 10.1128/AAC.05662-11. Epub 2011 Nov 28. Antimicrob Agents Chemother. 2012. PMID: 22123689 Free PMC article.

7

Design of tenofovir-UC781 combination microbicide vaginal gels.

Kiser PF, Mahalingam A, Fabian J, Smith E, Damian FR, Peters JJ, Katz DF, Elgendy H, Clark MR, Friend DR. Kiser PF, et al. Among authors: clark mr. J Pharm Sci. 2012 May;101(5):1852-64. doi: 10.1002/jps.23089. Epub 2012 Feb 22. J Pharm Sci. 2012. PMID: 22359356

8

Pharmacokinetics and topical vaginal effects of two tenofovir gels in rabbits.

Clark MR, Friend DR. Clark MR, et al. AIDS Res Hum Retroviruses. 2012 Nov;28(11):1458-66. doi: 10.1089/AID.2011.0328. Epub 2012 Apr 17. AIDS Res Hum Retroviruses. 2012. PMID: 22394281

9

Characterization of UC781-tenofovir combination gel products for HIV-1 infection prevention in an ex vivo ectocervical model.

Cost M, Dezzutti CS, Clark MR, Friend DR, Akil A, Rohan LC. Cost M, et al. Among authors: clark mr. Antimicrob Agents Chemother. 2012 Jun;56(6):3058-66. doi: 10.1128/AAC.06284-11. Epub 2012 Mar 19. Antimicrob Agents Chemother. 2012. PMID: 22430977 Free PMC article.

10

Development of polylactide and polyethylene vinyl acetate blends for the manufacture of vaginal rings.

Mc Conville C, Major I, Friend DR, Clark MR, Woolfson AD, Malcolm RK. Mc Conville C, et al. Among authors: clark mr. J Biomed Mater Res B Appl Biomater. 2012 May;100(4):891-5. doi: 10.1002/jbm.b.31919. Epub 2012 Mar 21. J Biomed Mater Res B Appl Biomater. 2012. PMID: 22438332

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

516 results

Search Page